Anzeige
Mehr »
Samstag, 14.02.2026 - Börsentäglich über 12.000 News
20 Mio. € Bewertung. Zwei zugelassene Psychedelika-Produkte. NASDAQ-Uplist in Arbeit.
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
392 Leser
Artikel bewerten:
(2)

Doceree Inc.: Empowering marketers with data-driven HCP engagement strategies, Doceree introduces the APAC edition of HIEP report

SHORT HILLS, N.J., April 8, 2025 /PRNewswire/ -- Following the success of its HIEP-UK/EU edition last year, Doceree, the world's first global network of physician-only platforms for programmatic messaging, today announced the launch of the second edition of HIEP, tailored for the APAC region. Curated independently, the report serves as a strategic guide for healthcare marketers, equipping them with data-driven insights to foster meaningful engagement with healthcare professionals (HCPs) in emerging APAC markets.

Empowering marketers with data-driven HCP engagement strategies, Doceree introduces the APAC edition of HIEP report

HIEP (High Interaction & Engagement Platforms) by Doceree has been introduced to address a critical gap in healthcare marketing today, i.e., the misalignment between media spends and HCP engagement on digital platforms. In an ideal world, investments in digital advertising must be directly proportional to the time healthcare professionals (HCPs) spend on various platforms. However, that is not the case as a significant portion of marketing budgets is often funnelled into channels that do not align with HCPs' actual digital behavior, but with the familiarity of accessing advertising inventory on few platforms, leading to inefficiencies and missed opportunities.

The HIEP Report aims to bridge this gap by providing pharmaceutical brands and agencies with data-driven insights into where and how HCPs engage online, enabling them to optimize their media spend for maximum impact. By mapping HCPs' digital footprints, the report empowers marketers to make informed, strategic decisions, ensuring their campaigns reach the right audience on the most relevant platforms.

Commenting on the launch of HIEP-APAC, Harshit Jain, MD, Founder & Global CEO, Doceree, said, "We are thrilled to introduce the APAC edition of our HIEP Report. This edition underscores how marketers can enhance HCP engagement and achieve significant outcomes by leveraging analytics, technology, and high-interaction platforms. By shifting from a push-oriented strategy to a collaborative, pull-driven approach, brands can establish more meaningful relationships with HCPs-and that's the exact approach this report aims to empower the pharma marketers with."

Some highlights from the HIEP Report (APAC Edition) are as below:

  • Exclusive insights into physician-frequented platforms
  • Proven strategies to enhance engagement quality and optimize marketing ROI
  • Real-world case study on the successful integration of digital platforms in healthcare marketing

Preetha Vasanji, President - Emerging Markets, Doceree, reinforced the importance of an integrated, omnichannel approach, saying, "The HIEP Report urges marketers to move beyond fragmented strategies and embrace a unified omnichannel approach. A well-orchestrated strategy amplifies every interaction with HCPs, leading to better engagement, stronger relationships, and ultimately, more effective healthcare solutions."

Click here to know more about the report - https://info.doceree.com/report-hiep-apac-hcp-engagement?hs_preview=NgdlhFSU-214465772738

About Doceree:

Leading the way in making HCP-patient conversations richer and more meaningful through patented responsive technology, Doceree addresses both current and emerging challenges for healthcare and life sciences organizations in HCP-patient engagement, particularly where digital and technological advancements play a crucial role. We leverage our patented technology to ensure that HCP-patient conversations and interactions are more meaningful, richer, and outcome-oriented. Learn more: www.doceree.com

Photo: https://mma.prnewswire.com/media/2659859/HIEP_report.jpg
Logo: https://mma.prnewswire.com/media/1758952/Doceree_Logo.jpg

(PRNewsfoto/Doceree Media India Pvt Ltd)

Cision View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/empowering-marketers-with-data-driven-hcp-engagement-strategies-doceree-introduces-the-apac-edition-of-hiep-report-302422797.html

© 2025 PR Newswire
Favoritenwechsel - diese 5 Werte sollten Anleger im Depot haben!
Das Börsenjahr 2026 ist für viele Anleger ernüchternd gestartet. Tech-Werte straucheln, der Nasdaq 100 tritt auf der Stelle und ausgerechnet alte Favoriten wie Microsoft und SAP rutschen zweistellig ab. KI ist plötzlich kein Rückenwind mehr, sondern ein Belastungsfaktor, weil Investoren beginnen, die finanzielle Nachhaltigkeit zu hinterfragen.

Gleichzeitig vollzieht sich an der Wall Street ein lautloser Favoritenwechsel. Während viele auf Wachstum setzen, feiern Value-Titel mit verlässlichen Cashflows ihr Comeback: Telekommunikation, Industrie, Energie, Pharma – die „Cashmaschinen“ der Realwirtschaft verdrängen hoch bewertete Hoffnungsträger.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau in dieses neue Marktbild passen: solide, günstig bewertet und mit attraktiver Dividende. Werte, die nicht nur laufende Erträge liefern, sondern auch bei Marktkorrekturen Sicherheit bieten.

Jetzt den kostenlosen Report sichern – bevor der Value-Zug 2026 endgültig abfährt!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.